IDO in Human Gut Graft-versus-Host Disease
Open Access
- 10 August 2011
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 18 (1), 150-155
- https://doi.org/10.1016/j.bbmt.2011.08.002
Abstract
No abstract availableFunding Information
- European Commission StemDiagnositics (LSHB-CT-2007-037703)
- Institut National du Cancer and Cancéropôle Ile de France, Conseil régional Ile de France, Agence de Biomédecine, and NIH (R01 AI34495, R01 CA 72 669, and R37 HL56067)
This publication has 18 references indexed in Scilit:
- A Crucial Role for Host APCs in the Induction of Donor CD4+CD25+ Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host DiseaseThe Journal of Immunology, 2010
- Th17/Treg ratio in human graft-versus-host diseaseBlood, 2010
- Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of T H 17 to Regulatory T Cells in HIV DiseaseScience Translational Medicine, 2010
- Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethalityBlood, 2009
- Acute graft-versus-host disease: from the bench to the bedsideBlood, 2009
- Granulocyte colony‐stimulating factor‐induced immature myeloid cells inhibit acute graft‐versus‐host disease lethality through an indoleamine dioxygenase‐independent mechanismImmunology, 2009
- Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in miceJournal of Clinical Investigation, 2008
- Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalityBlood, 2008
- Donor-derived cells and human graft-versus-host disease of the skinBlood, 2006
- Premature Induction of an Immunosuppressive Regulatory T Cell Response during Acute Simian Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 2006